- Netflix and TiVo signed licensing agreements that allow Netflix access to TiVo's patent portfolios and integrates Netflix into TiVo's offerings. [Business Wire]
- Despite the fact that intellectual property makes up a majority of many companies' valuable assets, it is generally not given much attention by decision makers, which leads to undervaluation or misrepresentation of a company's true worth. [Real Business]
- Soon after Fidel Castro came into power in Cuba, he abolished copyright protection nationwide. Because of artistic defections due to lost royalties, he reinstated copyright laws less than a decade later. [Amplify]
- 76ers center Joel Embiid has trademarked the phrase 'The Process' in an attempt to brand a future line of pre-bottled Shirley Temple drinks, along with other merchandise. [The Inquirer]
- With the advent of more efficient 3D printers, it is incumbent on designers and consumers to keep IP liabilities in mind and to steer clear of infringement risks. [TechCrunch]
- The winners of the John Scott Medal for their work on the CRISPER-Cas9 gene-editing technique are embroiled in a lawsuit over the patent rights, highlighting the disparities in the collaborative nature of research and the winner takes all approach to intellectual property. [The Inquirer]
On Thursday, Peter Cicala (Vice President of IP and Chief Patent Counsel of Celgene Corporation), Dr. Dora Mitchell, Director of UPstart and Assistant Director of PCI Ventures), and Dr. Michael Milone (Assistant Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania) spoke to PIPG and the Penn Science Policy Group about the process of commercializing research and common issues with research and development in the industrial setting. From the 12th floor of the Smilow Research Center, overlooking the Schuylkill river and the last remnants of industrial Philadelphia through floor-to-ceiling windows, the complex reality of the science and pharmaceutical patent process was starkly laid out.
Mr. Cicala discussed the legal history of patents. While they confer exclusivity, owning a patent does not mean that you can bring a product to market. His insider's knowledge of the biotech patent process revealed the importance of protecting intellectual property in all forms - and of always consulting a lawyer before disclosing new findings. He went through the painstaking process that attends filing for a patent and the different intellectual property rights conveyed across the international stage - did you know that patents are only granted in the US on Tuesdays?
Dr. Mitchell linked the private pharmaceutical patent process that Mr. Cicala described to that taking place on university campuses every day, including right there under Smilow's roof. Thanks to the Bayh-Dole Act of 1980, which conferred patent ownership to universities receiving federal research funds, the university patent industry exploded. With the added incentive of retaining royalty and other rights, research in universities such as Penn has become much more competitive - but also more restricted.
Dr. Milone, who runs a lab here at Penn and has funding from Novartis, outlined the tightrope a research professor must walk over the pressures of publishing and those of the free exchange of knowledge that attend scientific endeavors. He said that many of his graduate and post-doc students are not allowed to use the money from Novartis, because of stipulations as to how their work product might be disclosed. If unprotected intellectual property is released to the public - even in the form of a grant application accessible via FOIA - it no longer maintains legal standing as a novel idea (internationally, at least). Dr. Milone himself must confer with the legal team at UPenn before submitting papers to journals or engaging and sharing information with other laboratories.
While the costs are high, the benefits of patent protection outweigh them. The money that comes from such patents - in Dr. Malone's case, those related to artificial antigen receptors and signaling systems for the control of T cell specificity - helps to fund more research and supports hospitals and research institutions. The decades-long exclusivity that patents convey protects drug-producers' interests and, in the long run, makes the vast expense of complicated research and drug trials - and attorneys' and filing fees - worthwhile.
- There is a convincing argument that the policy toward stronger, more extensive intellectual property protection laws has contributed to economic inequality by empowering those who retain IP rights. [PBS NewsHour]
- With the incoming Trump administration, it is unclear who will be appointed to lead the PTO; experts expect a shift away from Silicon Valley due to Trump's critical views of the industry during his campaign. [Bloomberg BNP]
- Rubik's Cube has lost the battle to retain its 3D EU trademark because its special rotating capabilities are more suited to patent protection. [The New York Times]
- Universal Music Publishing Group purchased the administration rights to Prince's songs, which could mean that many of his songs will finally end up on YouTube and other streaming services. [The New York Times]
- According to a new survey by Deloitte, IP cybertheft is a growing concern across many different industries, portending danger for new startups and more established companies alike. [TechCrunch]
- A newly automated IP registration process is being expanded to 18 countries in Africa. With Microsoft's help, this new registration system could jumpstart Africa's innovation economy and make its small businesses more competitive in the global market. [Quartz]
Microsoft and Google agreed on Friday to withdraw complaints against each other with regulators around the world, as the two American tech giants continued recent efforts to settle the once-bitter conflicts between them. [The New York Times]
The pop music world suffered a huge loss on Thursday with the sudden death of Prince, who will be long remembered as one of the industry’s most innovative and influential stars. [WSJ]
The patent and trademark office's apparent drive to clear its backlog of applications has hit a legal roadblock, with the Tatas and a group of intellectual property attorneys dragging it to court. [The Economic Times]
Attorney fees awards are becoming more common in patent cases. A federal district judge awarded more than $4.1 million in such fees in a patent infringement case under 35 U.S.C. § 285, which allows attorney fees “in exceptional cases. [ABA News Archives]
The decade-long legal fight over Google's effort to create a digital library of millions of books is finally over. The Supreme Court declined to hear a challenge from the Authors Guild over their copyright battle with Google Books. [The Washington Post]
After filing an array of trademark infringement lawsuits over the past year against brands like Marc Jacobs, Forever 21, APL, and Skechers, adidas has named ECCO in an interesting new suit for allegedly infringing its three-stripe trademark. [The Fashion Law]